Global Biotherapeutics Cell Line Development Market Research Report 2021 – ResearchAndMarkets.com | Financial Buzz

Global Biotherapeutics Cell Line Development Market Research Report 2021 – ResearchAndMarkets.com

The “Biotherapeutics Cell Line Development – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Biotherapeutics Cell Line Development Market to Reach $110.3 Million by 2027

Amid the COVID-19 crisis, the global market for Biotherapeutics Cell Line Development estimated at US$72.6 Million in the year 2020, is projected to reach a revised size of US$110.3 Million by 2027, growing at a CAGR of 6.1% over the period 2020-2027.

Transfection & Selection, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$22.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Single Cell Cloning segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $21.5 Million, While China is Forecast to Grow at 5.7% CAGR

The Biotherapeutics Cell Line Development market in the U.S. is estimated at US$21.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.2 Million by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 42 Featured):

  • AGC Biologics
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • EMD Millipore Corporation
  • Lonza Group Ltd.
  • MilliporeSigma
  • ProBioGen AG
  • Selexis SA
  • Sony Biotechnology Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

     

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for Biotherapeutics Cell Line Development by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Historic Review for Biotherapeutics Cell Line Development by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • World 15-Year Perspective for Biotherapeutics Cell Line Development by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • World Current & Future Analysis for Transfection & Selection by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Historic Review for Transfection & Selection by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • World 15-Year Perspective for Transfection & Selection by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World Current & Future Analysis for Single Cell Cloning by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Historic Review for Single Cell Cloning by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • World 15-Year Perspective for Single Cell Cloning by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/yiub3l

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!